By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast
NEW YORK (Reuters Health) – Although trastuzumab is directed against the HER2 protein, patients with HER2-negative breast cancer may also benefit from adjuvant trastuzumab therapy, researchers report. They…
NEW YORK (Reuters Health) – How much an individual patient with esophageal cancer is likely to benefit, if at all, from chemoradiotherapy (CRT) before undergoing esophagectomy can be…
NEW YORK (Reuters Health) – A diagnosis of bladder cancer after an initial presentation with hematuria is often delayed in both men and women – but the delay…
NEW YORK (Reuters Health) – A preoperative MRI showing whether or not a rectal tumor encroaches on the circumferential resection margin (CRM) is a better predictor of recurrence…
NEW YORK (Reuters Health) – While pancreatic cancer mortality is still higher among blacks than whites in the US, rates are decreasing among blacks and increasing among whites,…
NEW YORK (Reuters Health) – In the neoadjuvant treatment of HER2-positive breast cancer, administering trastuzumab concurrently with anthracyclines offers no advantage over sequential administration, according to the results…
NEW YORK (Reuters Health) – Compared to single-agent platinum chemotherapy, platinum-combination chemotherapy improves survival in patients with recurrence of ovarian cancer, a meta-analysis has shown. The researchers say…
